Sudden 'Black Swan' Event! Senior Executive of Well-Known Semiconductor Company Detained Over Alleged Criminal Offense | Post-Market Announcement Highlights

A senior executive of a well-known technology company has been detained on suspicion of criminal offenses! A robotics concept stock announced that its core products, including dexterous hands, have achieved scaled supply; a long-established information services company plans to launch a 10-billion-yuan financial leasing business…

Golden10 Data14minutes ago

Optical Fiber Bull Stock Clarification: The Company Has No Business Relationship with NVIDIA! | After-Hours Announcement Highlights

Optical fiber stock urgently clarifies no connection with NVIDIA! Stock with five limit-up days in seven trading sessions issues risk warning; pharmaceutical giant announces its holding subsidiary has signed an exclusive option agreement.

Golden10 DataMay 13 21:02

No business relationship with NVIDIA whatsoever! A 33 billion yuan fiber-optic concept stock releases clarification announcement | Post-market announcements summary

China Jushi: Plans to invest 4.431 billion yuan in building a production line project for 50,000 tons of electronic yarn and 320 million meters of electronic cloth annually

cls.cnMay 13 20:42

Two controlling persons of the CRO giant are under investigation by the CSRC! | Selected After-Hours Announcements

Two controlling shareholders of a CRO giant have been investigated by the CSRC! A well-known liquor company announced that its actual controller has changed to the Municipal Finance Bureau; a wind power giant urgently clarified that its shareholder is not a popular male star...

Golden10 DataMay 12 21:06

Suspected of violations and illegal activities related to information disclosure on shareholding changes! The actual controller of a 40 billion CRO leading company has been investigated by the CSRC | Post-market announcement highlights

Vanke A: Shenzhen Metro Group provides the company with a RMB 2.5 billion shareholder loan facility, and the company signs a supplementary agreement for the RMB 22 billion shareholder loan.

cls.cnMay 12 20:51

Another deal! Hengrui Pharma partners with BMS in strategic collaboration with a potential transaction value of $15.2 billion | Flash Report

① Hengrui and BMS have signed an agreement to jointly advance 13 early-stage projects covering oncology, hematology, and immunology; ② BMS will pay an upfront fee of $600 million and an anniversary payment of $350 million, with milestone payments reaching approximately $15.2 billion. Hengrui is also entitled to receive sales royalties; ③ This represents a two-way licensing collaboration, with Hengrui obtaining the rights to four of BMS's immunology projects in China. The agreement is expected to close in the third quarter of 2026.

cls.cnMay 12 14:49